arrow
H

Hélène Cavé

universite paris cite
H指数:77
被引数:1.9万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Identification of favorable subgroups of pediatric high-hyperdiploid acute lymphoblastic leukemia—A retrospective multinational study

识别儿童高超二倍体急性淋巴细胞白血病有利亚组——一项多国回顾性研究

2026-09-180
OAAI
Biological and clinical characteristics of ETV6::RUNX1-like ALL

ETV6::RUNX1样急性淋巴细胞白血病的生物学和临床特征

2026-04-170
OA
Maturity Onset Diabetes of the Young (MODY): French National Diagnosis and Care Protocol (PNDS, Protocole National de Diagnostic et de Soins)

青年成熟期发病糖尿病(MODY):法国国家诊断与治疗方案(PNDS,Protocole National de Diagnostic et de Soins)

2026-03-310
OAAI
The watch-and-wait approach for patients with juvenile myelomonocytic leukemia: results of the French cohort

对于儿童骨髓单核细胞白血病患者采取的观察等待策略:法国队列研究的结果

Blood
IF23.1
2025-09-220
PRE
Neurofibromatosis-Noonan syndrome: a prospective monocentric study of 26 patients and literature review

神经纤维瘤病-Noonan综合征:一项前瞻性单中心研究(纳入26例患者)及文献综述

2025-04-270
OA
Overt and covert genetic causes of pediatric acute lymphoblastic leukemia

儿童急性淋巴细胞白血病的显性及隐性遗传病因

LEUKEMIA
IF13.4
2025-03-240
PRE
PAX5::AUTS2 childhood B-ALL: a relapse-prone genetic subtype with frequent central nervous system involvement and a poor outcome: ACUTE LYMPHOBLASTIC LEUKEMIA
LEUKEMIA
IF13.4
2024-12-190
OAAI
Results of the prospective EORTC Children Leukemia Group study 58081 in precursor B- and T-cell acute lymphoblastic leukemia
2024-11-130
OAAI
How to Administer Pegaspargase during Induction Treatment of Acute Lymphoblastic Leukemia in Children and Adolescents? Results of the Caall-F01, a Multicentre Randomized Clinical Trial from the French Pediatric Cancer Society (SFCE)

如何在儿童和青少年急性淋巴细胞白血病的诱导治疗期间使用Pegaspargase?Caall-F01研究结果,一项来自法国儿科肿瘤学会(SFCE)的多中心随机临床试验。

BLOOD
IF23.1
2024-11-050
PRE
Psychological and ethical issues raised by genomic in paediatric care pathway, a qualitative analysis with parents and childhood cancer patients
2024-07-134
OAAI
Loss-of-function variants in ERF are associated with a Noonan syndrome-like phenotype with or without craniosynostosis
2024-06-013
PRE
Analysis of measurable residual disease by IG/TR gene rearrangements: quality assurance and updated EuroMRD guidelines
LEUKEMIA
IF13.4
2024-05-145
OAAI
Differential activation of basal and IL-7-induced PI3K/Akt/ mTOR and JAK/STAT5 signaling distinguishes pediatric from adult acute lymphoblastic leukemia
2024-04-240
OAAI